Clinical Trials
All Clinical Trials - Page 34 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT03937882Phase 3Completed
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3
TB-500
- NCT03923114N/ACompleted
Imaging Pituitary ActiVation by Exendin
Exenatide
- NCT05029076Phase 1Completed
Human Bioequivalence Test of Liraglutide Injection
Liraglutide
- NCT04019197Phase 2Active Not Recruiting
Effects of Semaglutide in HIV-Associated Lipohypertrophy
Semaglutide
- NCT03951831Phase 2Active Not Recruiting
REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer
Gonadorelin
- NCT03961256Phase 2Completed
Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation
Exenatide
- NCT03811561Phase 3Active Not Recruiting
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes
Semaglutide
- NCT03861052Phase 3Completed
A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes
Tirzepatide
- NCT04185350EARLY_Phase 1Unknown
Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma
Exenatide
- NCT03919929Phase 2/Phase 3Completed
Treating PCOS With Semaglutide vs Active Lifestyle Intervention
Semaglutide
- NCT04648969Phase 2Completed
Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism
Kisspeptin
- NCT03645408Phase 1Terminated
The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers
Exenatide
- NCT03899402Phase 2/Phase 3Active Not Recruiting
Triple Therapy in T1DM
Semaglutide
- NCT03940495N/ACompleted
Serum Kisspeptin: a Predictive Marker of Miscarriage or Not?
Kisspeptin
- NCT04034524N/AUnknown
Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin
Liraglutide
- NCT03860688Phase 2/Phase 3Unknown
Effects of Oral Glucose and Teduglutide on Plasma Lipoproteins
Teduglutide
- NCT03809429Phase 3Completed
Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND)
Gonadorelin
- NCT04189900Phase 1Completed
Generation of Biological Samples Positive to Triptorelin for Anti-doping Control
Gonadorelin
- NCT03862716Phase 3Completed
Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira
Liraglutide
- NCT03883776Phase 1Completed
Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors
Octreotide
- NCT04366726Phase 1Completed
Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD)
Abaloparatide
- NCT03899077Phase 2Unknown
Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP
Gonadorelin
- NCT03882970Phase 3Completed
A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
Tirzepatide
- NCT03878381EARLY_Phase 1Completed
Investigating the Wrinkle Reduction Potential of a Novel Compounded Skin Care Cream
Argireline
- NCT03696121Phase 2Completed
Desmopressin for Reversal of Antiplatelet Drugs in Stroke Due to Haemorrhage
Desmopressin
- NCT03861039Phase 3Completed
A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
Tirzepatide
- NCT03891875Phase 2Completed
ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA
Elamipretide
- NCT03790865Phase 2/Phase 3Terminated
Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome
Ghrp-6
- NCT03856632Phase 4Active Not Recruiting
Liraglutide Effect in Atrial Fibrillation
Liraglutide
- NCT03881995Phase 4Terminated
Effects of Insulin Glargine and Lixisenatide on the Brain
Lixisenatide
- NCT03841630Phase 1Completed
A Safety Study of LY3437943 Given as a Single Injection in Healthy Participants
Retatrutide
- NCT03767543Phase 3Completed
Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM)
Lixisenatide
- NCT03792555Phase 2Completed
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve)
Octreotide
- NCT03888157N/ACompleted
A Research Study Looking at How Victoza® Works in People With Type 2 Diabetes in Iran, Followed in Local Clinical Routine
Liraglutide
- NCT03743025Phase 4Terminated
Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients
Dulaglutide
- NCT03955575Phase 4Completed
Treatment of Bile Acid Malabsorption With Liraglutide
Liraglutide
- NCT04536467Phase 2Unknown
Prevention of Chemotherapy-Induced Ovarian Failure With Goserelin in Premenopausal Lymphoma Patients
Gonadorelin
- NCT03856047Phase 2Completed
Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.
Cagrilintide
- NCT03993366N/ACompleted
Pramlintide and Fiasp Closed-Loop With a Simple Meal Announcement
Pramlintide
- NCT03770338N/AActive Not Recruiting
Preoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion Surgery
Teriparatide
- NCT03846180N/ACompleted
Terlipressin on Effect of Renal Function in Cirrhotic Patients With Acute Gastrointestinal Hemorrhage
Octreotide
- NCT03642600Phase 4Completed
The Gut Microbiome in Women With Polycystic Ovary Syndrome
Liraglutide
- NCT03883412Phase 4Recruiting
Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)
Liraglutide
- NCT03798080Phase 3Completed
Comparison of the Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Ratio Combination to Insulin Glargine in Patients With Type 2 Diabetes Insufficiently Controlled on Basal Insulin
Lixisenatide
- NCT03798054Phase 3Completed
Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s)
Lixisenatide
- NCT03746041Phase 1Completed
A Phase I Pilot Study of Abaloparatide + Bevacizumab in Myelodysplastic Syndromes
Abaloparatide
- NCT03835013N/ACompleted
Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers
Exenatide
- NCT03800875Phase 2Completed
Insulin-plus-pramlintide Closed-loop Strategy to Regulate Glucose Levels Without Carbohydrate Counting
Pramlintide
- NCT03520569EARLY_Phase 1Completed
Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults
Octreotide
- NCT06725693N/ARecruiting
Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease
Exenatide